Search Results 761-770 of 18625 for Relapse
In a study of axicabtagene ciloleucel (axi-cel) CAR-T cell therapy for relapsed or refractory aggressive B-cell lymphoma, 30-day responses were comparable ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
ANSWER: The rate of colorectal cancer survival five years after initial diagnosis has been on the rise. But with survival comes a new risk — that of ...
... Relapsed and Lenalidomide-Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic ...
It may be combined with chemotherapy or targeted therapy. Immunotherapy also may be used for relapsed or refractory Waldenstrom macroglobulinemia. Bone marrow ...
... relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) ...
This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT ( ...
... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. First · Previous ... 340 · 341 · 342 · 343 · 344 · 345 · 346 ... Next · Last.
Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to improve quality of life after lymphoma treatment. Publications. See a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.